IBD: Ustekinumab shows promise in the treatment of refractory Crohn's disease
- PMID: 23147667
- DOI: 10.1038/nrgastro.2012.213
IBD: Ustekinumab shows promise in the treatment of refractory Crohn's disease
Comment on
-
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.N Engl J Med. 2012 Oct 18;367(16):1519-28. doi: 10.1056/NEJMoa1203572. N Engl J Med. 2012. PMID: 23075178 Clinical Trial.
References
-
- N Engl J Med. 2012 Oct 18;367(16):1519-28 - PubMed
Publication types
LinkOut - more resources
Full Text Sources